Perrigo(PRGO) - 2024 Q2 - Quarterly Results

EXHIBIT 99.1 Perrigo Reports Second Quarter 2024 Financial Results From Continuing Operations Delivered Adjusted Diluted Earnings Per Share Results as Expected; Reaffirm Fiscal 2024 Adjusted Diluted EPS Outlook Progressing One Perrigo Blueprint: On Target to Deliver Project Energize Goals; Enhancing Capabilities; Completed Divestment of HRA Pharma Rare Diseases Business on July 10, 2024 Second Quarter 2024 Highlights: 1 • Net sales of $1.1 billion declined 10.7% versus the prior year quarter. Organic net sa ...